Brigitte A. Adams - Publications

The Burden of BK Polyomavirus in Pediatric Renal Transplantation: A Belgian Experience.

Journal: Biomedicines

Published: November 03, 2025

Clinical and genetic characteristics of patients diagnosed with atypical hemolytic uremic syndrome (aHUS): epidemiological data from the Belgian cohort of the Global aHUS Registry.

Journal: Journal of nephrology

Published: February 06, 2025

Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intention.

Journal: Journal of tissue viability

Published: August 09, 2024

Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials.

Journal: Kidney medicine

Published: August 06, 2024

Minutes matter for life safety and risk exposure in Milford Sound, New Zealand.

Journal: Scientific reports

Published: June 17, 2024

Clinical outcomes of pediatric kidney replacement therapy after childhood cancer-An ESPN/ERA Registry study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 22, 2024

Illness-related parental stress and quality of life in children with kidney diseases.

Journal: Pediatric nephrology (Berlin, Germany)

Published: August 25, 2022

Hyperoxaluria: An early diagnosis will allow a timely combined renal and liver transplantations to avoid irreversible damages to all other organs.

Journal: Journal of translational internal medicine

Published: February 09, 2022

Wastewater-based epidemiology in hazard forecasting and early-warning systems for global health risks.

Journal: Environment international

Published: October 21, 2021

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1.

Journal: Frontiers in pediatrics

Published: October 08, 2021

Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.

Journal: BMC nephrology

Published: September 22, 2021

Correction to: The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab.

Journal: Pediatric nephrology (Berlin, Germany)

Published: December 09, 2020